Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation

  title={Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation},
  author={Maxine X. Patel and Faisil Nasim Sethi and Thomas R. E. Barnes and Roland Dix and Luiz Dratcu and Bernard Fox and Marina Garriga and Julie C. Haste and Kai G. Kahl and Anne Lingford-Hughes and Hamish McAllister-Williams and Aileen O'Brien and Caroline Parker and Brodie Paterson and Carol Paton and Sotiris Posporelis and David Taylor and Eduard Vieta and Birgit A. V{\"o}llm and Charlotte Wilson-Jones and Laura Woods},
  journal={Journal of Psychopharmacology},
  pages={601 - 640}
The British Association for Psychopharmacology and the National Association of Psychiatric Intensive Care and Low Secure Units developed this joint evidence-based consensus guideline for the clinical management of acute disturbance. It includes recommendations for clinical practice and an algorithm to guide treatment by healthcare professionals with various options outlined according to their route of administration and category of evidence. Fundamental overarching principles are included and… 

Tables from this paper

Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change

The evolving treatment paradigm and the place of inhaled medications for acutely agitated patients both within and outside the emergency and hospital setting are discussed.

Antipsychotic Drugs or Benzodiazepines for Rapid Tranquilization in Mental Health Facilities or Emergency Department Settings

Evidence from 5 systematic reviews, 3 randomized controlled trials, and 4 observational studies provide inconsistent evidence regarding the comparative efficacy and safety of antipsychotic drugs and

Rapid tranquillisation: the science and advice

  • J. Cookson
  • Medicine, Psychology
    BJPsych Advances
  • 2018
This article reviews critically the practice of rapid tranquillisation in the light of new evidence, changes in the NICE guidelines and British National Formulary recommendations and a national audit (POMH-UK).

Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond

This review covers the pharmacological and clinical history of loxapine along with research developments and emphasizes the advantages of its multiple formulations ranging from injectable forms and tablets to orally inhaled forms to attain rapid and fine-tuned tranquilization.

Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation

Examination of evidence available in the literature and clinical algorithms suggested by the authors for sequential medication administration in patients with persistent acute agitation in psychiatric emergency settings discuss risk factors for medication-related adverse events and provide options for patients who are able to take oral medications and for Patients who require parenteral intervention.

Alternatives to the Use of Mechanical Restraints in the Management of Agitation or Aggressions of Psychiatric Patients: A Scoping Review

Training in de-escalation techniques, risk assessment, and implementation of the “six core strategies” or “Safewards” program were the most assessed and effective interventions to reduce aggressive behaviors and the use of coercive measures.

Risperidone for rapid tranquilisation: more evidence required

  • Dtb selecT
  • Psychology, Medicine
    Drug and Therapeutics Bulletin
  • 2019
The authors concluded that the results cast uncertainty on the role of risperidone in rapid tranquillisation for people with psychosisinduced aggression.

The Utilization of a Rapid Agitation Scale and Treatment Protocol for Patient and Staff Safety in an Inpatient Psychiatric Setting

It is suggested that including a rapid agitation assessment and protocol within the EMR potentially improves nurses’ perceptions of unit safety, helps assess treatment response, reduces time patients spend restrained, and supports decision making for nurses.

Physical health monitoring after rapid tranquillisation: clinical practice in UK mental health services

The findings prompt speculation that post-RT monitoring practice would be improved by the implementation of guidance that integrated and refined the currently separate systems for undertaking and recording physical health observations post- RT, determining nursing observation schedules and detecting acute deterioration in physical health.

Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.

Among patients with mild to moderate agitation associated with bipolar disorder, treatment with a sublingual film formulation of dexmedetomidine 120 μg or 180 μg, compared with placebo, resulted in significantly greater reduction in the agitation score at 2 hours.



Current rapid tranquillisation documents in the UK: a review of the drugs recommended, their routes of administration and clinical parameters influencing their use

There is a need to rationalise rapid tranquillisation and develop consensus guidelines that allow for evidence based decision-making tools, as well as investigate the wide variation and sometimes absence of advice surrounding these parameters.

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.

A prospective study of high dose sedation for rapid tranquilisation of acute behavioural disturbance in an acute mental health unit

Large initial doses of sedative drugs were used for ABD in just over half of cases and additional sedation was uncommon and high dose sedation did not result in more rapid or effective sedation but was associated with more adverse effects.

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine

Midazolam was more rapidly sedating than haloperidol-promethazine, reducing the time people are exposed to aggression, and should be considered in the choice of the treatment.

A growing evidence base for management guidelines: Revisiting... Guidelines for the management of acutely disturbed psychiatric patients

A simple protocol for oral or intramuscular rapid tranquillisation is presented and staff using physical restraint should be properly trained and consider sensitively issues of the patient's diginity, gender and the most appropriate location for restraint to occur.

Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine

Haloperidol plus promethazine is a better option than haloperidl alone in terms of speed of onset of action and safety.

Orally Versus Intramuscularly Administered Antipsychotic Drugs in Psychiatric Emergencies

Oral administered second generation (atypical) antipsychotics have been shown to be at least as effective in managing acute agitation as conventional antipsychotic drugs, with a superior tolerability profile.

Emergency management of agitation in pregnancy.